International health officials say two experimental drugs used to treat Ebola infections appear to be saving lives in the Democratic Republic of the Congo. Dr. Anthony Fauci of the U.S. National Institutes of Health called the early results some very good news. He said the new drugs may be able to improve the survival of people with Ebola. The NIH helped support the research. The findings come from a study of four different drugs that started in November of last year. But an independent monitoring group recommended last week that the study be ended early. The group recommended that all new patients should receive either of the two drugs that showed the best results. The drugs are antibodies that work by blocking the virus in the body.